Cargando…

Persistent endotheliopathy in the pathogenesis of long COVID syndrome

BACKGROUND: Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS‐CoV‐2 infection. The biological mechanisms underlying this “long COVID” syndrome remain unknown. However, autopsy studies have highlighted the key roles...

Descripción completa

Detalles Bibliográficos
Autores principales: Fogarty, Helen, Townsend, Liam, Morrin, Hannah, Ahmad, Azaz, Comerford, Claire, Karampini, Ellie, Englert, Hanna, Byrne, Mary, Bergin, Colm, O’Sullivan, Jamie M., Martin‐Loeches, Ignacio, Nadarajan, Parthiban, Bannan, Ciaran, Mallon, Patrick W., Curley, Gerard F., Preston, Roger J.S., Rehill, Aisling M., McGonagle, Dennis, Ni Cheallaigh, Cliona, Baker, Ross I., Renné, Thomas, Ward, Soracha E., O’Donnell, James S., O’Connell, Niamh, Ryan, Kevin, Kenny, Dermot, Fazavana, Judicael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420256/
https://www.ncbi.nlm.nih.gov/pubmed/34375505
http://dx.doi.org/10.1111/jth.15490
_version_ 1783748901505859584
author Fogarty, Helen
Townsend, Liam
Morrin, Hannah
Ahmad, Azaz
Comerford, Claire
Karampini, Ellie
Englert, Hanna
Byrne, Mary
Bergin, Colm
O’Sullivan, Jamie M.
Martin‐Loeches, Ignacio
Nadarajan, Parthiban
Bannan, Ciaran
Mallon, Patrick W.
Curley, Gerard F.
Preston, Roger J.S.
Rehill, Aisling M.
McGonagle, Dennis
Ni Cheallaigh, Cliona
Baker, Ross I.
Renné, Thomas
Ward, Soracha E.
O’Donnell, James S.
O’Connell, Niamh
Ryan, Kevin
Kenny, Dermot
Fazavana, Judicael
author_facet Fogarty, Helen
Townsend, Liam
Morrin, Hannah
Ahmad, Azaz
Comerford, Claire
Karampini, Ellie
Englert, Hanna
Byrne, Mary
Bergin, Colm
O’Sullivan, Jamie M.
Martin‐Loeches, Ignacio
Nadarajan, Parthiban
Bannan, Ciaran
Mallon, Patrick W.
Curley, Gerard F.
Preston, Roger J.S.
Rehill, Aisling M.
McGonagle, Dennis
Ni Cheallaigh, Cliona
Baker, Ross I.
Renné, Thomas
Ward, Soracha E.
O’Donnell, James S.
O’Connell, Niamh
Ryan, Kevin
Kenny, Dermot
Fazavana, Judicael
author_sort Fogarty, Helen
collection PubMed
description BACKGROUND: Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS‐CoV‐2 infection. The biological mechanisms underlying this “long COVID” syndrome remain unknown. However, autopsy studies have highlighted the key roles played by pulmonary endotheliopathy and microvascular immunothrombosis in acute COVID‐19. OBJECTIVES: To assess whether endothelial cell activation may be sustained in convalescent COVID‐19 patients and contribute to long COVID pathogenesis. PATIENTS AND METHODS: Fifty patients were reviewed at a median of 68 days following SARS‐CoV‐2 infection. In addition to clinical workup, acute phase markers, endothelial cell (EC) activation and NETosis parameters and thrombin generation were assessed. RESULTS: Thrombin generation assays revealed significantly shorter lag times (p < .0001, 95% CI −2.57 to −1.02 min), increased endogenous thrombin potential (p = .04, 95% CI 15–416 nM/min), and peak thrombin (p < .0001, 95% CI 39–93 nM) in convalescent COVID‐19 patients. These prothrombotic changes were independent of ongoing acute phase response or active NETosis. Importantly, EC biomarkers including von Willebrand factor antigen (VWF:Ag), VWF propeptide (VWFpp), and factor VIII were significantly elevated in convalescent COVID‐19 compared with controls (p = .004, 95% CI 0.09–0.57 IU/ml; p = .009, 95% CI 0.06–0.5 IU/ml; p = .04, 95% CI 0.03–0.44 IU/ml, respectively). In addition, plasma soluble thrombomodulin levels were significantly elevated in convalescent COVID‐19 (p = .02, 95% CI 0.01–2.7 ng/ml). Sustained endotheliopathy was more frequent in older, comorbid patients, and those requiring hospitalization. Finally, both plasma VWF:Ag and VWFpp levels correlated inversely with 6‐min walk tests. CONCLUSIONS: Collectively, our findings demonstrate that sustained endotheliopathy is common in convalescent COVID‐19 and raise the intriguing possibility that this may contribute to long COVID pathogenesis.
format Online
Article
Text
id pubmed-8420256
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis
record_format MEDLINE/PubMed
spelling pubmed-84202562021-09-07 Persistent endotheliopathy in the pathogenesis of long COVID syndrome Fogarty, Helen Townsend, Liam Morrin, Hannah Ahmad, Azaz Comerford, Claire Karampini, Ellie Englert, Hanna Byrne, Mary Bergin, Colm O’Sullivan, Jamie M. Martin‐Loeches, Ignacio Nadarajan, Parthiban Bannan, Ciaran Mallon, Patrick W. Curley, Gerard F. Preston, Roger J.S. Rehill, Aisling M. McGonagle, Dennis Ni Cheallaigh, Cliona Baker, Ross I. Renné, Thomas Ward, Soracha E. O’Donnell, James S. O’Connell, Niamh Ryan, Kevin Kenny, Dermot Fazavana, Judicael J Thromb Haemost Brief Report BACKGROUND: Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS‐CoV‐2 infection. The biological mechanisms underlying this “long COVID” syndrome remain unknown. However, autopsy studies have highlighted the key roles played by pulmonary endotheliopathy and microvascular immunothrombosis in acute COVID‐19. OBJECTIVES: To assess whether endothelial cell activation may be sustained in convalescent COVID‐19 patients and contribute to long COVID pathogenesis. PATIENTS AND METHODS: Fifty patients were reviewed at a median of 68 days following SARS‐CoV‐2 infection. In addition to clinical workup, acute phase markers, endothelial cell (EC) activation and NETosis parameters and thrombin generation were assessed. RESULTS: Thrombin generation assays revealed significantly shorter lag times (p < .0001, 95% CI −2.57 to −1.02 min), increased endogenous thrombin potential (p = .04, 95% CI 15–416 nM/min), and peak thrombin (p < .0001, 95% CI 39–93 nM) in convalescent COVID‐19 patients. These prothrombotic changes were independent of ongoing acute phase response or active NETosis. Importantly, EC biomarkers including von Willebrand factor antigen (VWF:Ag), VWF propeptide (VWFpp), and factor VIII were significantly elevated in convalescent COVID‐19 compared with controls (p = .004, 95% CI 0.09–0.57 IU/ml; p = .009, 95% CI 0.06–0.5 IU/ml; p = .04, 95% CI 0.03–0.44 IU/ml, respectively). In addition, plasma soluble thrombomodulin levels were significantly elevated in convalescent COVID‐19 (p = .02, 95% CI 0.01–2.7 ng/ml). Sustained endotheliopathy was more frequent in older, comorbid patients, and those requiring hospitalization. Finally, both plasma VWF:Ag and VWFpp levels correlated inversely with 6‐min walk tests. CONCLUSIONS: Collectively, our findings demonstrate that sustained endotheliopathy is common in convalescent COVID‐19 and raise the intriguing possibility that this may contribute to long COVID pathogenesis. The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis 2021-10 2022-12-21 /pmc/articles/PMC8420256/ /pubmed/34375505 http://dx.doi.org/10.1111/jth.15490 Text en © 2021 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Report
Fogarty, Helen
Townsend, Liam
Morrin, Hannah
Ahmad, Azaz
Comerford, Claire
Karampini, Ellie
Englert, Hanna
Byrne, Mary
Bergin, Colm
O’Sullivan, Jamie M.
Martin‐Loeches, Ignacio
Nadarajan, Parthiban
Bannan, Ciaran
Mallon, Patrick W.
Curley, Gerard F.
Preston, Roger J.S.
Rehill, Aisling M.
McGonagle, Dennis
Ni Cheallaigh, Cliona
Baker, Ross I.
Renné, Thomas
Ward, Soracha E.
O’Donnell, James S.
O’Connell, Niamh
Ryan, Kevin
Kenny, Dermot
Fazavana, Judicael
Persistent endotheliopathy in the pathogenesis of long COVID syndrome
title Persistent endotheliopathy in the pathogenesis of long COVID syndrome
title_full Persistent endotheliopathy in the pathogenesis of long COVID syndrome
title_fullStr Persistent endotheliopathy in the pathogenesis of long COVID syndrome
title_full_unstemmed Persistent endotheliopathy in the pathogenesis of long COVID syndrome
title_short Persistent endotheliopathy in the pathogenesis of long COVID syndrome
title_sort persistent endotheliopathy in the pathogenesis of long covid syndrome
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420256/
https://www.ncbi.nlm.nih.gov/pubmed/34375505
http://dx.doi.org/10.1111/jth.15490
work_keys_str_mv AT fogartyhelen persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT townsendliam persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT morrinhannah persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT ahmadazaz persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT comerfordclaire persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT karampiniellie persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT englerthanna persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT byrnemary persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT bergincolm persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT osullivanjamiem persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT martinloechesignacio persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT nadarajanparthiban persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT bannanciaran persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT mallonpatrickw persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT curleygerardf persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT prestonrogerjs persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT rehillaislingm persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT mcgonagledennis persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT nicheallaighcliona persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT bakerrossi persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT rennethomas persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT wardsorachae persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT odonnelljamess persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT oconnellniamh persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT ryankevin persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT kennydermot persistentendotheliopathyinthepathogenesisoflongcovidsyndrome
AT fazavanajudicael persistentendotheliopathyinthepathogenesisoflongcovidsyndrome